cancer treatments

Chemo brain

“Chemo brain”: 3 surprising findings from recent research

“Chemo brain” — the term for cognitive problems associated with chemotherapy treatment — appears to be very common, but doctors only started paying attention to it in the late 1990s. A 2012 study that finally helped elevate chemo brain as a serious and widespread issue estimated that up to 75% of breast cancer survivors experience “cognitive deficits—problems with

“Chemo brain”: 3 surprising findings from recent research Read More »

CyberKnife, VATS + other surgical and less invasive treatments for lung cancer

Surgery is among the most common treatments for people with lung cancer. Let’s take a closer look at various types of surgery for lung cancer, as well as emerging non-surgical and minimally invasive treatments, like CyberKnife or “SBRT,” cryosurgery and “VATS.” Huh? Read on… we’ll explain. Common types of lung cancer surgery Before we explore

CyberKnife, VATS + other surgical and less invasive treatments for lung cancer Read More »

What’s in your “chemo bag”? Gearing up for lung cancer treatment

Chemotherapy is one of the most common treatments for lung cancer, so the community on PatientsLikeMe is chatting about what’s helpful to pack in a bag for chemo appointments (join PatientsLikeMe to take part in this lung cancer forum discussion). Everyone’s experiences, side effects and preferences are different, but here are some items that people who’ve had chemotherapy say

What’s in your “chemo bag”? Gearing up for lung cancer treatment Read More »

2 immunotherapy treatments in the news: Imfinzi and Keytruda update

Two immunotherapy treatments — Imfinzi (durvalumab) and Keytruda (pembrolizumab) — have made headlines recently in relation to lung cancer treatment. What’s the latest? Here’s an update. Expanded FDA approval for Imfinzi The U.S. Food and Drug Administration (FDA) first approved Imfinzi as a bladder cancer treatment in 2017. Imfinzi is marketed by AstraZeneca. In February 2018, the FDA approved

2 immunotherapy treatments in the news: Imfinzi and Keytruda update Read More »

PatientsLikeMe and M2Gen Announce Partnership and Plans for Landmark Cancer Experience Study

  CAMBRIDGE, Mass. & TAMPA, Fla., March 8, 2016—Patient network PatientsLikeMe® and informatics solutions provider M2Gen® are collaborating to give patients and researchers a more complete picture of patients’ experiences with cancer treatments and to shed new light on the factors that may affect outcomes and quality of life. The partnership aims to advance cancer

PatientsLikeMe and M2Gen Announce Partnership and Plans for Landmark Cancer Experience Study Read More »

Scroll to Top